Met proto-oncogene and insulin-like growth factor binding protein 3 overexpression correlates with metastatic ability in well-differentiated pancreatic endocrine neoplasms

被引:116
作者
Hansel, DE
Rahman, A
House, M
Ashfaq, R
Berg, K
Yeo, CJ
Maitra, A
机构
[1] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA
[4] Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75230 USA
关键词
D O I
10.1158/1078-0432.CCR-04-0285
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pancreatic endocrine neoplasms are neoplastic proliferations of islet cells or islet cell precursors and are capable of secreting a variety of synthetic products, including insulin, glucagon, gastrin, and vasoactive intestinal peptide. The biological behavior of pancreatic endocrine neoplasms is often unpredictable, and there are few,reliable histopathologic criteria reliably correlating with metastatic ability. We have used the Affymetrix U133 GeneChip set (HG_U133 A and B; Affymetrix; Santa Clara, CA) representing similar to33,000 characterized transcripts to examine global gene expression profiles from well-differentiated nonmetastatic (n = 5) and metastatic (n = 7) pancreatic endocrine neoplasms to determine molecular markers that predict disease progression. Microarray hybridization data were normalized using the GeneLogic GeneExpress Software System to identify differentially up- and down-regulated genes in metastatic versus nonmetastatic pancreatic endocrine neoplasms. Using a 3-fold change in gene expression as a threshold, we have identified 65 overexpressed and 57 underexpressed genes in metastatic pancreatic endocrine neoplasms as compared with nonmetastatic pancreatic endocrine neoplasms. Several classes of genes, including growth factors and growth factor-related molecules (IGFBP1, IGFBP3, and MET), developmental factors (TBX3 and MEIS2), cytoskeletal factors (P I tubulin and ACTN2), cholesterol homeostasis mediators (LRP5, SLC27A2, and RXRG), intracellular signaling pathway mediators (DYRK1A, PKIB, and AK2), methyltransferases (MGMT and GAMT), and DNA repair and regulatory molecules (CHEK1 and ZNF198), were identified as differentially over- or underexpressed via this method. Immunohistochemical validation of microarray data were performed for two overexpressed genes, namely, the met protooncogene (MET) and insulin-like growth factor binding protein 3 (IGFBP3) with tissue microarrays of nonmetastatic (n = 24) and metastatic (n = 15) pancreatic endocrine neoplasms. Increased expression of IGFBP3 was confirmed in metastatic versus nonmetastatic pancreatic endocrine neoplasms (12 of 15, 80% versus 10 of 24, 42%), as well as in lymph node (6 of 7, 86%) and liver (9 of 9, 100%) metastases. Similarly, overexpression of MET was confirmed in metastatic versus nonmetastatic pancreatic endocrine neoplasms (5 of 15, 33% versus 4 of 24, 17%), as well as in lymph node metastases (4 of 7, 57%) and liver metastases (5 of 9, 56%). The majority of genes that demonstrated altered expression has not been previously identified-as differentially expressed in metastatic pancreatic endocrine neoplasm lesions and may therefore represent newly identified molecules in the progression of these lesions.
引用
收藏
页码:6152 / 6158
页数:7
相关论文
共 37 条
[1]   Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas [J].
Alonso, ME ;
Bello, MJ ;
Gonzalez-Gomez, P ;
Arjona, D ;
Lomas, J ;
de Campos, JM ;
Isla, A ;
Sarasa, JL ;
Rey, JA .
CANCER GENETICS AND CYTOGENETICS, 2003, 144 (02) :134-142
[2]   Low frequency of p16INK4a alterations in insulinomas [J].
Bartsch, DK ;
Kersting, M ;
Wild, A ;
Ramaswamy, A ;
Gerdes, B ;
Schuermann, M ;
Simon, B ;
Rothmund, M .
DIGESTION, 2000, 62 (2-3) :171-177
[3]  
Beghelli S, 1998, J PATHOL, V186, P41, DOI 10.1002/(SICI)1096-9896(199809)186:1<41::AID-PATH172>3.0.CO
[4]  
2-L
[5]   Membrane dynamics, cholesterol homeostasis, and Alzheimer's disease [J].
Chauhan, NB .
JOURNAL OF LIPID RESEARCH, 2003, 44 (11) :2019-2029
[6]  
Cupisti K, 2000, EUR J CLIN INVEST, V30, P325
[7]   Evidence for a Niemann-Pick C (NPC) gene family: Identification and characterization of NPC1L1 [J].
Davies, JP ;
Levy, B ;
Ioannou, YA .
GENOMICS, 2000, 65 (02) :137-145
[8]  
Ferry RJ, 1999, HORM RES, V51, P53
[9]   Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion [J].
Fujino, T ;
Asaba, H ;
Kang, MJ ;
Ikeda, Y ;
Sone, H ;
Takada, S ;
Kim, DH ;
Ioka, RX ;
Ono, M ;
Tomoyori, H ;
Okubo, M ;
Murase, T ;
Kamataki, A ;
Yamamoto, J ;
Magoori, K ;
Takahashi, S ;
Miyamoto, Y ;
Oishi, H ;
Nose, M ;
Okazaki, M ;
Usui, S ;
Imaizumi, K ;
Yanagisawa, M ;
Sakai, J ;
Yamamoto, TT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (01) :229-234
[10]   Insulin-like growth factors and cancer [J].
Fürstenberger, G ;
Senn, HJ .
LANCET ONCOLOGY, 2002, 3 (05) :298-302